These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35849091)

  • 81. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
    Zhong F; Yu T; Ma X; Wang S; Cong Q; Tao X
    Dis Markers; 2022; 2022():8130373. PubMed ID: 35722626
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
    Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
    J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.
    Tao X; Zhang H; Li J; Zhang H; Xiao J; Zhang L; Zhou X; Sui L; Wang L; Zhao C
    Cancer Cytopathol; 2019 Oct; 127(10):650-657. PubMed ID: 31532582
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
    Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
    Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
    Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
    JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
    Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 90. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
    Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
    J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Scrutinizing high-risk patients from ASC-US cytology via a deep learning model.
    Tao X; Chu X; Guo B; Pan Q; Ji S; Lou W; Lv C; Xie G; Hua K
    Cancer Cytopathol; 2022 Jun; 130(6):407-414. PubMed ID: 35290728
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
    Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
    [No Abstract]   [Full Text] [Related]  

  • 94. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
    Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Machine Learning Interpretation of Extended Human Papillomavirus Genotyping by Onclarity in an Asian Cervical Cancer Screening Population.
    Wong OGW; Ng IFY; Tsun OKL; Pang HH; Ip PPC; Cheung ANY
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31511337
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests?
    Samimi SA; Mody RR; Goodman S; Luna E; Armylagos D; Schwartz MR; Mody DR; Ge Y
    Arch Pathol Lab Med; 2018 Mar; 142(3):347-352. PubMed ID: 29160722
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population-Cobas and Aptima HPV tests.
    Wong OGW; Tsun OKL; Tsui EY; Chow JNK; Ip PPC; Cheung ANY
    J Clin Virol; 2018 Dec; 109():13-18. PubMed ID: 30368218
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
    Chatzistamatiou K; Moysiadis T; Moschaki V; Panteleris N; Agorastos T
    Gynecol Oncol; 2016 Jul; 142(1):120-127. PubMed ID: 27126005
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.
    Placidi A; Capparucci P; Di Luzio A; Manca G; Mania E; Filippini T; Giorgi Rossi P
    Acta Cytol; 2016; 60(5):458-464. PubMed ID: 27504992
    [TBL] [Abstract][Full Text] [Related]  

  • 100. HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Lie AK; Tropé A; Skare GB; Bjørge T; Jonassen CM; Brusegard K; Lönnberg S
    Gynecol Oncol; 2018 Jan; 148(1):111-117. PubMed ID: 29132873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.